Health Canada MIFISO product monograph, 2022Linepharma International LimitedLink: [hres.ca](C17-2) Medical abortion, 2016Journal of Obstetrics and Gynaecology CanadaLink: [sogc-ma](C14) Canadian protocol for the provision of medical abortion via […]
Training and Webinars
SOGC’s medical abortion training program, 2024Link: sogc-training NAF Canada’s medication abortion training for primary care providers, 2023Link: nafc-training
Checklists and Resource Guides
Checklist for starting medical abortion services,National Abortion Federation.Link: naf-checklist Medical abortion prescriber checklist resource guide,Planned Parenthood, the University of British Columbia & CART Access Project.Link: ma-resource-guide Medical […]
Indigenous patients
Below are suggestions to help non-Indigenous healthcare professionals create an inclusive environment for Indigenous patients. These suggestions are not exhaustive and providers are encouraged to […]
2SLGBTQIA+ patients
Below are some suggestions to help clinicians create an inclusive environment where the needs of 2SLGBTQIA+ patients can be met. These suggestions are not exhaustive […]
Non-insured patients
Providers can support non-insured patients by:
Federal insurance schemes
Patients who are covered through Federal programs, may request a prescription for Mifegymiso and fill it at a pharmacy of their choice and it will […]
Addressing abortion concerns
Below are suggestions on how to address opposition and concerns about medication abortion (MA) among your staff and colleagues, which will facilitate smooth integration of […]
Facility Setup
Below is a general guide of the steps to be taken when initiating medication abortion (MA) services in your facility. Some of these may not […]
Regulatory landscape
Abortion is legal in Canada, and patients do not require consent from partners or parents to seek an abortion. It is the second most common reproductive health service: one […]
